CARBIDOPA

作品数：8被引量：5H指数：2
导出分析报告
相关领域：医药卫生更多>>
相关作者：李若华崔建国范磊冯瑞更多>>
相关机构：广西师范学院更多>>
相关期刊：《Advances in Parkinson's Disease》《Advanced Fiber Materials》《化工技术与开发》《中华物理医学与康复杂志》更多>>
相关基金：广西壮族自治区自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-8
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Liquid Subcutaneous Levodopa-Carbidopa ND0612 Effects on Motor Symptoms in Individuals with Parkinson’s Disease: A Systematic Review and Meta-Analysis
《Advances in Parkinson's Disease》2024年第2期9-25,共17页Paula Abola Mitchell Wolden Kristin Lefebvre 
Objective: In the manuscript titled “Liquid subcutaneous Levodopa-Carbidopa ND0612 effects on motor symptoms in individuals with Parkinson’s Disease: A systematic review and meta-analysis”, the objective was to con...
关键词：Parkinson’s Disease ND0612 Levodopa-Carbidopa Motor Symptoms Motor Complications UPDRS 
Why do‘OFF’periods still occur during continuous drug delivery in Parkinson’s disease?
《Translational Neurodegeneration》2022年第1期280-293,共14页Silvia Rota Daniele Urso Daniel J.van Wamelen Valentina Leta Iro Boura Per Odin Alberto J.Espay Peter Jenner K.Ray Chaudhuri 
Continuous drug delivery(CDD)is used in moderately advanced and late-stage Parkinson’s disease(PD)to control motor and non-motor fluctuations(‘OFF’periods).Transdermal rotigotine is indicated for early fluctuations...
关键词：‘OFF’periods Continuous drug delivery Continuous dopaminergic stimulation Rotigotine patch Subcutaneous apomorphine infusion Levodopa-carbidopa intestinal gel 
Fabrication of Electrospun Levodopa-Carbidopa Fixed-Dose Combinations被引量：2
《Advanced Fiber Materials》2020年第4期194-203,共10页Haitham Bukhary Gareth R.Williams Mine Orlu 
Introduction Parkinson’s disease(PD)is a disabling disorder that signifi-cantly affects a patient’s quality of life[1].Treatments are available,but only 10%of PD patients fully adhere to their treatment regimens[2]....
关键词：ELECTROSPINNING NANOFIBER Fixed-dose combination POLYPHARMACY 
Non-Motor Symptoms in Parkinson’s Disease Patients—An Observational Study
《Journal of Biosciences and Medicines》2020年第6期1-16,共16页Thomas Gabriel Schreiner 
Background: Parkinson’s disease (PD) remains a challenge for neurologists, particularly in its advanced stages when non-motor symptoms become a burden for the patient. While motor symptoms may be sat...
关键词：Parkinson’s Disease Non-Motor Symptoms Conventional Treatment Levodopa/Carbidopa Intestinal Gel 
Levodopa/Carbidopa Intestinal Gel for Treatment of Advanced Parkinson’s Disease: An Update on the Effects of Cognitive Functions被引量：1
《Advances in Parkinson's Disease》2017年第1期13-23,共11页Pamela Latino Stefania Tagliente Clelia Pellicano Morena Giovannelli Francesco E. Pontieri 
Cognitive impairment is a frequent non-motorsymptom of Parkinson’s disease (PD). In early disease stage, this takes the features of dysexecutive syndrome, and is mostly dependent on derangement of frontostriatal circ...
关键词：Cognition DEMENTIA DOPAMINE Replacement Therapy Duodopa LEVODOPA Parkinson’s Disease 
Levodopa-carbidopa intestinal gel for advanced Parkinson＇s disease
《中华物理医学与康复杂志》2016年第3期179-179,共1页
关键词：左旋多巴疗法 肠凝 起伏现象 单一疗法 
Recent advances in pharmacological therapy of Parkinson’s disease: Levodopa and carbidopa protective effects against DNA oxidative damage
《Health》2012年第11期1191-1199,共9页Monica Colamartino Luca Padua Tommaso Cornetta Antonella Testa Renata Cozzi 
Parkinson’s disease is one of the most common progressive neurodegenerative disorder. It is characterized by the depletion of dopamine in the dopaminergic neurons of the striatum of the brain. Pharmacological treatme...
关键词：Parkinson’s DISEASE LEVODOPA CARBIDOPA Protective Effects 
多巴类药物的研究进展被引量：2
《化工技术与开发》2007年第2期22-26,共5页冯瑞 崔建国 范磊 李若华 
广西自然科学基金(批准号:桂科基0575055)资助
综述了甲基多巴和卡比多巴这2种多巴类药物的合成方法进展,全文涉及了18篇参考文献。
关键词：左旋多巴(L-DOPA) L-甲基多巴(L-Methyldopa) 卡比多巴(L-Carbidopa) 合成 
全选清除导出
共1页<1>
检索报告 对象比较 聚类工具 使用帮助 返回顶部